25 Jan

Analysts Give Mixed Signals on Chevron Stock

WRITTEN BY Maitali Ramkumar

Analysts’ ratings for Chevron

In this series so far, we’ve reviewed Chevron’s (CVX) 4Q17 earnings estimates, segment-wise outlook, stock performance, and stock price forecast. The company is set to publish its earnings results on February 2, 2018. In this part, we’ll review analyst ratings for Chevron.

Analysts Give Mixed Signals on Chevron Stock

Of the 24 analysts covering CVX in January 2018, 14 (58%) analysts recommended “buy” or “strong buy,” nine (38%) recommended “hold,” and one (4%) recommended “sell.” To learn more about these recommendations, read Analysts’ Ratings for Chevron: Why Most Call It a ‘Buy’.

Changes in analysts’ ratings and target prices

Chevron stock has seen mixed signals from Wall Street analysts in January 2018. While BMO has upgraded Chevron, HSBC has downgraded it.

BMO has upgraded Chevron from “market perform” to “outperform,” and raised CVX’s target price from $120 per share to $140 per share. HSBC has raised CVX’s target price from $125 per share to $133 per share, and downgraded Chevron from “buy” to “hold.”

Many other investment banking companies have raised CVX’s target prices. Morgan Stanley raised its target price for Chevron stock from $130 per share to $145 per share, and Jefferies, which has a “buy” rating on the stock, increased its target price to $152 per share. Deutsche Bank raised CVX’s target price from $131 per share to $145 per share. CVX’s mean target price of $135 per share implies a 3% gain from its current level.

Analysts’ ratings for peers

Peers Statoil (STO), Total (TOT), and YPF (YPF) have been rated “buy” by 20%, 17%, and 100% of analysts, respectively. ExxonMobil (XOM), BP (BP), and Royal Dutch Shell (RDS.A) have been rated “buy” by 32%, 46%, and 91% of analysts. In the next part, we’ll evaluate short interest changes in Chevron.

Latest articles

This year, Pfizer (PFE) stock has fallen 0.34% and Bristol-Myers Squibb (BMY) stock has fallen 6.48%. Both companies are focused on strengthening their position in the high-growth oncology and immunology markets. Let's take a closer look at each.

Walt Disney’s (DIS) latest movie, Toy Story 4, has reportedly broken records in the opening weekend with $118 million in sales. However, the opening weekend collection was behind analysts’ expectations of at least $150 million in the first weekend.

24 Jun

Will Home Depot’s Upward Momentum to Continue?

WRITTEN BY Rajiv Nanjapla

As of June 21, Home Depot (HD) was trading at $209.39, which implies a rise of 9.7% since the announcement of its first-quarter earnings on May 21. Also, the company was trading at a premium of 32.4% from its 52-week low of $158.09 and a discount of 2.8% from its 52-week high of $215.43.

On June 21, Aurora Cannabis (ACB) made an announcement that indicated that it will move towards higher margin vape products. In addition, the company also believes concentrates and edibles will command higher margins. In anticipation of this development, the company announced the expansion of its facility to capitalize on growth related to these segments.

Shares of Mondelēz International (MDLZ) are scaling new heights thanks to its stellar gains so far this year. Mondelēz stock is up 38.0% on a YTD (year-to-date) basis, and it closed at $55.25—just a shade lower than its 52-week high of $55.71—on June 21.

24 Jun

How Long Will Facebook's Libra Fuel Bitcoin Rally?

WRITTEN BY Mayur Sontakke, CFA, FRM

Ever since the news about Facebook’s (FB) cryptocurrency project broke, Bitcoin has rallied on the hope that Facebook’s entry in the space will help make cryptocurrencies mainstream. Facebook’s cryptocurrency will be called Libra and will be governed by an association with 28 founding members across industries.